カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

近赤外線イメージングの世界市場予測（～2028）：製品別、処置別、用途別、エンドユーザー別、地域別

■ 英語タイトル：Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：MD4138-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：MD4138-23
■ 発行日：2023年6月30日
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：233
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[近赤外線イメージングの世界市場予測（～2028）：製品別、処置別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

マーケッツアンドマーケッツ社は、世界の近赤外線イメージング市場規模が2023年の10億ドルから2028年には19億ドルに達し、2023年から2028年までの年平均成長率は14.0%と予測しています。当調査レポートは、近赤外線イメージングの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（デバイス、NIRイメージング剤/プローブ、近赤外線染料）分析、処置別（癌手術、消化器外科、心臓血管疾患、形成外科／再建外科、その他）分析、用途別（前臨床イメージング、臨床イメージング、医療イメージング）分析、エンドユーザー別（病院＆外科クリニック、製薬＆バイオテクノロジー企業、研究所＆学術機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東/アフリカ、中南米）分析、競争状況などの内容を記載しています。なお、当市場の主要企業には、Stryker (US)、KARL STORZ SE & Co. KG (Germany)、Carl Zeiss Meditec AG (Germany)、Leica Microsystems (US)、Olympus Corporation (Japan)、PerkinElmer, Inc. (US)、LI-COR, Inc. (US)、Medtronic (Ireland)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の近赤外線イメージング市場規模：製品別
　 - 近赤外線イメージングデバイスの市場規模
　 - NIRイメージング剤/プローブの市場規模
　 - 近赤外線染料の市場規模
・世界の近赤外線イメージング市場規模：処置別
　 - 癌手術における市場規模
　 - 消化器外科における市場規模
　 - 心臓血管疾患における市場規模
　 - 形成外科／再建外科における市場規模
　 - その他処置における市場規模
・世界の近赤外線イメージング市場規模：用途別
　 - 前臨床用近赤外線イメージングの市場規模
　 - 臨床用近赤外線イメージングの市場規模
　 - 医療用近赤外線イメージングの市場規模
・世界の近赤外線イメージング市場規模：エンドユーザー別
　 - 病院＆外科クリニックにおける市場規模
　 - 製薬＆バイオテクノロジー企業における市場規模
　 - 研究所＆学術機関における市場規模
　 - その他エンドユーザーにおける市場規模
・世界の近赤外線イメージング市場規模：地域別
　 - 北米の近赤外線イメージング市場規模
　 - ヨーロッパの近赤外線イメージング市場規模
　 - アジア太平洋の近赤外線イメージング市場規模
　 - 中東/アフリカの近赤外線イメージング市場規模
　 - 中南米の近赤外線イメージング市場規模
・競争状況
・企業情報

“世界の近赤外線イメージング市場は、2023年の10億米ドルから2028年には19億米ドルに達し、2023年から2028年までの年平均成長率は14.0%と予測”
対象疾患の罹患率/有病率の高さ、画像診断センター/処置数の増加、疾患の早期診断の利点に関する意識の高まり、技術的に先進的なNIRモダリティの急速な採用などの要因が、この市場の成長拡大の要因となっています。

“NIRデバイスセグメントの近赤外蛍光イメージングサブシステムセグメントが2022年に市場で最大シェアを獲得”
製品別に見ると、近赤外線イメージング市場はNIRデバイス、NIRイメージング剤/プローブ、NIR色素に区分されます。NIRデバイス市場は、さらに近赤外蛍光イメージングシステムと近赤外蛍光・生物発光イメージングシステムに分けられます。市場では近赤外蛍光イメージングシステムが主要シェアを占めています。近赤外蛍光イメージングシステムが提供する高感度、高解像度、手術中のリアルタイム画像ガイダンスなどの利点がこの製品セグメントの成長を牽引しています。

“前臨床アプリケーション分野は予測期間中に最も高いCAGRを記録すると予測”
アプリケーションに基づき、近赤外線イメージング市場は前臨床、臨床、医療に大別されます。前臨床イメージングとは、医薬品開発などの研究目的で生きた動物を可視化することです。科学者が生体メカニズムを検出・監視し、体内の治療反応を正確に測定・提供するのに役立ちます。がん、炎症、血管新生、感染症、血管疾患などの疾患/病態に対する新たな治療法の開発に注目が集まっていることが、予測期間中にこの応用分野の成長を促進すると予想されています。

“癌手術セグメントは予測期間中最高のCAGRを記録すると予測”
手技に基づき、近赤外線イメージング市場は癌手術、消化器手術、心臓血管手術、形成/再建手術、脳腫瘍手術に大別されます。世界中で癌の有病率が上昇していることが、このセグメントの成長を促進する主な要因です。

“北米地域の市場は予測期間中に最も高い成長を目撃する見込み”
北米地域の近赤外線イメージング市場は、予測期間中にCAGRを記録することが期待されています。その主な理由は、同地域における高い医療費、対象疾患の有病率の上昇、研究活動の増加、美容整形手術の増加、イメージングシステムの技術進歩などです。

本レポートで参照した主要参入企業の内訳は以下の通りです：
– 企業タイプ別 ティア1-48%、ティア2-36%、ティア3-16％
– 役職別 ディレクターレベル-14%、Cレベル-10%、その他-76％
– 地域別 北米-40%、欧州-32%、アジア太平洋地域-20%、中南米-5%、中東・アフリカ-3％

近赤外線イメージング市場の主要企業は、Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Medtronic (Ireland) です。

調査範囲
この調査レポートは、近赤外線イメージング市場を製品、手順、用途、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、本レポートでは、ミクロ市場の成長動向を分析し、主要5地域（およびこれらの地域の各国）に関する市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、近赤外線イメージング市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
– 近赤外線イメージング市場の成長に影響を与える主な促進要因（対象患者数の増加、マルチモーダルPETイメージング装置の採用拡大、技術進歩、官民組織による投資・資金・助成金の増加）、抑制要因（資本コストと運用コストの高さ、不利な規制ガイドライン）、機会（新興国における医療インフラの改善、乳房イメージングにおけるPETの利用、有望な製品パイプライン）、課題（代替イメージング技術の利用可能性）分析
– 製品開発/イノベーション： 近赤外線イメージング市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細な洞察
– 市場開発： 有利な市場に関する包括的な情報-当レポートは、様々な地域の近赤外線イメージング市場を分析
– 市場の多様化： 新製品、未開拓地域、最新動向、近赤外線イメージング市場への投資に関する詳細情報
– 競合評価： Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and Medtronic (Ireland)など主要企業の市場シェア、成長戦略、サービス提供の詳細な評価

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 24
1.3 MARKETS COVERED 25
1.3.1 MARKET SEGMENTATION 25
1.3.2 REGIONAL SEGMENTATION 25
1.4 YEARS CONSIDERED 26
1.5 CURRENCY CONSIDERED 26
1.6 RESEARCH LIMITATIONS 26
1.7 STAKEHOLDERS 27
1.8 SUMMARY OF CHANGES 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
FIGURE 1 NEAR INFRARED IMAGING MARKET: RESEARCH DESIGN 28
2.1.1 SECONDARY RESEARCH 29
2.1.2 PRIMARY RESEARCH 30
2.1.2.1 Primary sources 30
2.1.2.2 Key industry insights 31
2.1.2.3 Breakdown of primaries 32
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND SIDE PARTICIPANTS 32
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.2 MARKET SIZE ESTIMATION 32
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 33
2.2.1 BOTTOM-UP APPROACH 34
2.2.1.1 Approach 1: Company revenue estimation approach 34
FIGURE 5 APPROACH 1: MARKET SIZE ESTIMATION (COMPANY REVENUE ESTIMATION) 34
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF STRYKER 35
2.2.1.2 Approach 2: Customer-based market estimation 35
FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH 36
2.2.1.3 CAGR projections 36
FIGURE 8 CAGR PROJECTION: SUPPLY SIDE ANALYSIS 36
2.3 DATA TRIANGULATION 37
FIGURE 9 DATA TRIANGULATION METHODOLOGY 37
2.4 MARKET SHARE ASSESSMENT 38
2.5 STUDY ASSUMPTIONS 38
2.6 RISK ASSESSMENT 38
2.6.1 NEAR-INFRARED IMAGING MARKET: RISK ASSESSMENT 38
2.7 GROWTH RATE ASSUMPTIONS 39
2.8 NEAR-INFRARED IMAGING MARKET: RECESSION IMPACT 39
3 EXECUTIVE SUMMARY 40
FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 40
FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 41
FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 GEOGRAPHICAL SNAPSHOT: NEAR-INFRARED IMAGING MARKET 44
4 PREMIUM INSIGHTS 45
4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW 45
FIGURE 15 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET 45
4.2 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT (2023 VS. 2028) 46
FIGURE 16 DEVICES SEGMENT TO DOMINATE NORTH AMERICAN NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD 46
4.3 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER (2023 VS. 2028) 46
FIGURE 17 HOSPITALS & SURGICAL CLINICS TO FORM LARGEST END USER SEGMENT IN ASIA PACIFIC MARKET 46
4.4 GLOBAL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE (2023 VS. 2028) 47
FIGURE 18 FLUORESCENCE IMAGING SYSTEMS SEGMENT TO HOLD LARGEST SHARE DURING STUDY PERIOD 47
4.5 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET 47
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 20 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Increasing number of surgical procedures globally 49
5.2.1.2 Advantages of near-infrared imaging over conventional visualization methods 50
TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS 50
5.2.1.3 Technological advancements in near-infrared imaging modalities 50
5.2.1.4 Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging 51
5.2.2 RESTRAINTS 51
5.2.2.1 Lengthy approval process of near-infrared fluorophores 51
5.2.2.2 High initial capital and operational costs of near-infrared systems 52
5.2.2.3 Availability of alternate technologies 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Growth potential for major players in emerging economies 52
5.2.3.2 Use of blockchain for distribution and storage of medical images 53
5.2.4 CHALLENGES 53
5.2.4.1 Hospital budget cuts 53
5.2.4.2 Dearth of trained professionals in emerging economies 53
5.3 PORTER’S FIVE FORCES ANALYSIS 54
TABLE 2 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 54
5.3.1 THREAT OF NEW ENTRANTS 55
5.3.2 THREAT OF SUBSTITUTES 55
5.3.3 BARGAINING POWER OF SUPPLIERS 55
5.3.4 BARGAINING POWER OF BUYERS 55
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.4 REGULATORY ANALYSIS 56
5.4.1 NORTH AMERICA 56
5.4.1.1 US 56
TABLE 3 US: APPROVED IMAGING DEVICES BY FDA 56
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 57
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 57
5.4.1.2 Canada 58
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
5.4.2 EUROPE 58
5.4.3 ASIA PACIFIC 59
5.4.3.1 Japan 59
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 59
5.4.3.2 China 60
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 60
5.4.3.3 India 61
5.5 REIMBURSEMENT SCENARIO ANALYSIS 61
TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (AS OF 2021) 62
5.6 ECOSYSTEM MAPPING 62
5.7 VALUE CHAIN ANALYSIS 63
5.7.1 RESEARCH & PRODUCT DEVELOPMENT 63
5.7.2 RAW MATERIAL AND MANUFACTURING 63
5.7.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES 63
FIGURE 21 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 64

5.8 SUPPLY CHAIN ANALYSIS 64
5.8.1 PROMINENT COMPANIES 64
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES 64
5.8.3 END USERS 64
TABLE 10 SUPPLY CHAIN ECOSYSTEM OF NEAR-INFRARED IMAGING MARKET 65
FIGURE 22 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS 66
5.9 PATENT ANALYSIS 67
FIGURE 23 PATENT DETAILS FOR NEAR-INFRARED IMAGING (JANUARY 2013–MAY 2023) 67
FIGURE 24 PATENT DETAILS FOR NEAR-INFRARED FLUORESCENCE IMAGING SYSTEMS (JANUARY 2013–MAY 2023) 68
FIGURE 25 PATENT DETAILS FOR NEAR-INFRARED DYES (JANUARY 2013–MAY 2023) 69
5.10 TRADE ANALYSIS 70
5.10.1 TRADE ANALYSIS: NEAR-INFRARED IMAGING MARKET 70
TABLE 11 IMPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD) 70
TABLE 12 EXPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD) 70
5.11 KEY CONFERENCES AND EVENTS (2023–2025) 71
TABLE 13 NEAR-INFRARED IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025) 71
5.12 TECHNOLOGY ANALYSIS 72
5.13 CASE STUDY ANALYSIS 73
5.13.1 TECHNOLOGICAL CHALLENGES 73
TABLE 14 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 73
5.13.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING 73
TABLE 15 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES 73
5.14 PRICING ANALYSIS 74
TABLE 16 REGION-WISE PRICE RANGE FOR NEAR-INFRARED IMAGING SYSTEMS 74
6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 17 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 76
6.2 DEVICES 76
TABLE 18 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 76
TABLE 19 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 20 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY APPLICATION, 2021–2028 (USD MILLION) 77
TABLE 21 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION) 78
TABLE 22 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY END USER, 2021–2028 (USD MILLION) 78
6.2.1 FLUORESCENCE IMAGING SYSTEMS 78
6.2.1.1 Higher sensitivity and better real-time image guidance during surgeries to drive market 78
TABLE 23 FLUORESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS 80
6.2.2.1 Better sensitivity and higher efficiency at lower costs to drive market 80
TABLE 24 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.3 NIR IMAGING AGENTS/PROBES 81
TABLE 25 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 81
TABLE 26 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 27 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY APPLICATION, 2021–2028 (USD MILLION) 82
TABLE 28 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY PROCEDURE, 2021–2028 (USD MILLION) 83
TABLE 29 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY END USER, 2021–2028 (USD MILLION) 83
6.3.1 INDOCYANINE GREEN 84
6.3.1.1 Increasing utilization of small organic probes in near-infrared imaging to drive segment 84
TABLE 30 INDOCYANINE GREEN MARKET, BY REGION, 2021–2028 (USD MILLION) 84
6.3.2 OTHER REAGENTS 85
6.3.2.1 Other reagents to provide specific functionalities and properties for better imaging process 85
TABLE 31 OTHER REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 85
6.4 NIR DYES 85
TABLE 32 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 33 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 34 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 35 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY PROCEDURE, 2021–2028 (USD MILLION) 87
TABLE 36 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY END USER, 2021–2028 (USD MILLION) 88
6.4.1 ORGANIC DYES 88
6.4.1.1 Unique molecular structure and better compatibility with biological systems to drive segment 88
TABLE 37 ORGANIC DYES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
6.4.2 NANOPARTICLE DYES 89
6.4.2.1 Better brightness and enhanced signal intensity compared to organic dyes to drive segment 89
TABLE 38 NANOPARTICLE DYES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE 91
7.1 INTRODUCTION 92
TABLE 39 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 92
7.2 CANCER SURGERIES 92
TABLE 40 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 41 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2021–2028 (USD MILLION) 93
7.2.1 BRAIN CANCER/TUMOR SURGERIES 94
7.2.1.1 Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market 94
TABLE 42 BRAIN CANCER/TUMOR SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
7.2.2 OTHER CANCER SURGERIES 95
7.2.2.1 Better tissue penetration and lower autofluorescence levels to drive market 95
TABLE 43 OTHER CANCER SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
7.3 GASTROINTESTINAL SURGERIES 96
TABLE 44 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 45 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2021–2028 (USD MILLION) 97
7.3.1 COLORECTAL SURGERIES 97
7.3.1.1 Advancements in treatment strategies and procedures to drive market 97
TABLE 46 COLORECTAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
7.3.2 OTHER GASTROINTESTINAL SURGERIES 98
7.3.2.1 Precise visualization of near-infrared imaging to drive market 98
TABLE 47 OTHER GASTROINTESTINAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
7.4 CARDIOVASCULAR DISEASES 99
7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET 99
TABLE 48 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 100
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES 100
7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO DRIVE MARKET 100
TABLE 49 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2021–2028 (USD MILLION) 101
7.6 OBSTETRICS & GYNECOLOGY SURGERIES 101
7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO DRIVE MARKET 101
TABLE 50 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2021–2028 (USD MILLION) 102
7.7 OTHER PROCEDURES 103
TABLE 51 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2021–2028 (USD MILLION) 103
8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 52 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
8.2 PRECLINICAL IMAGING 105
8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET 105
TABLE 53 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 106
8.3 CLINICAL IMAGING 106
8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO DRIVE MARKET 106
TABLE 54 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 107
8.4 MEDICAL IMAGING 107
8.4.1 APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET 107
TABLE 55 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING, BY REGION, 2021–2028 (USD MILLION) 108
9 NEAR-INFRARED IMAGING MARKET, BY END USER 109
9.1 INTRODUCTION 110
TABLE 56 NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 110
9.2 HOSPITALS & SURGICAL CLINICS 110
9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET 110
TABLE 57 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2021–2028 (USD MILLION) 111
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 111
9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO DRIVE MARKET 111
TABLE 58 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 112
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 112
9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO DRIVE MARKET 112
TABLE 59 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 113
9.5 OTHER END USERS 114
TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 114
10 NEAR-INFRARED IMAGING MARKET, BY REGION 115
10.1 INTRODUCTION 116
TABLE 61 NEAR-INFRARED IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 116
10.2 NORTH AMERICA 117
FIGURE 26 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT 117
TABLE 62 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 63 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 64 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 65 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 66 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 67 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 68 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 120
TABLE 69 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 120
10.2.1 US 121
10.2.1.1 Advanced healthcare infrastructure and favorable regulations to drive market 121
TABLE 70 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 121
TABLE 71 US: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 72 US: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 73 US: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 122
10.2.2 CANADA 123
10.2.2.1 Increased availability of research funding to drive market 123
TABLE 74 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 123
TABLE 75 CANADA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 76 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 77 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 124
10.3 EUROPE 125
TABLE 78 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 79 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
TABLE 80 EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 81 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 82 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 83 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 84 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 127
TABLE 85 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.3.1 GERMANY 128
10.3.1.1 Increasing healthcare expenditure and government spending to drive market 128
TABLE 86 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 129
TABLE 87 GERMANY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 88 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 89 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 130
10.3.2 FRANCE 130
10.3.2.1 Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market 130
TABLE 90 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 131
TABLE 91 FRANCE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 92 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 93 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 132
10.3.3 UK 132
10.3.3.1 Growing government initiatives and increasing incidences of chronic diseases to drive market 132
TABLE 94 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 132
TABLE 95 UK: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 96 UK: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 97 UK: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 133
10.3.4 ITALY 134
10.3.4.1 Increased availability of reimbursement coverage for diagnostic procedures to drive market 134
TABLE 98 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 134
TABLE 99 ITALY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 100 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 101 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR DYE, BY TYPE, 2021–2028 (USD MILLION) 135
10.3.5 SPAIN 136
10.3.5.1 Increasing prevalence of cancer and growing private-public funding to drive market 136
TABLE 102 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 103 SPAIN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 104 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 105 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 137
10.3.6 REST OF EUROPE 138
TABLE 106 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 107 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 108 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 109 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 139
10.4 ASIA PACIFIC 140
FIGURE 27 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT 140
TABLE 110 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 111 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 112 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 113 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 114 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 115 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 116 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 143
TABLE 117 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.4.1 CHINA 144
10.4.1.1 Increasing healthcare reforms and government investments to drive market 144
TABLE 118 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 145
TABLE 119 CHINA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 120 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 121 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 146
10.4.2 JAPAN 146
10.4.2.1 Fast adoption of advanced technologies and growth in geriatric population to drive market 146
TABLE 122 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 123 JAPAN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 124 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 148
TABLE 125 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 148
10.4.3 INDIA 148
10.4.3.1 Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market 148
TABLE 126 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 127 INDIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 128 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 129 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 150
10.4.4 AUSTRALIA 150
10.4.4.1 Growing healthcare spending and increasing investments in research to drive market 150
TABLE 130 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 131 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 132 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 133 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 152
10.4.5 SOUTH KOREA 152
10.4.5.1 Presence of advanced healthcare system and increased awareness about diseases to drive market 152
TABLE 134 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 135 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 136 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 137 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 154
10.4.6 REST OF ASIA PACIFIC 154
TABLE 138 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 139 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 140 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 141 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 156
10.5 LATIN AMERICA 157
TABLE 142 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 143 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 144 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 145 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 146 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 147 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 148 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 159
TABLE 149 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.5.1 BRAZIL 160
10.5.1.1 Greater purchasing power and more favorable demographic conditions to drive market 160
TABLE 150 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 160
TABLE 151 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 152 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 153 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 161
10.5.2 MEXICO 162
10.5.2.1 Increased medical tourism and better government healthcare initiatives to drive market 162
TABLE 154 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 155 MEXICO: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 156 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 157 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 163
10.5.3 REST OF LATIN AMERICA 163
TABLE 158 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 159 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 160 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 161 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 165
10.6 MIDDLE EAST & AFRICA 165
10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET 165
TABLE 162 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 163 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 164 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 165 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 166 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 167 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 168
TABLE 168 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11 COMPETITIVE LANDSCAPE 169
11.1 OVERVIEW 169
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 169
11.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY PLAYERS IN NEAR-INFRARED IMAGING MARKET 169
11.3 REVENUE SHARE ANALYSIS 169
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022 170
11.4 MARKET SHARE ANALYSIS 170
FIGURE 29 MARKET SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022 170
TABLE 169 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION 171
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 172
11.5.1 STARS 172
11.5.2 EMERGING LEADERS 172
11.5.3 PERVASIVE PLAYERS 172
11.5.4 PARTICIPANTS 172
FIGURE 30 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 173
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 174
11.6.1 PROGRESSIVE COMPANIES 174
11.6.2 STARTING BLOCKS 174
11.6.3 RESPONSIVE COMPANIES 174
11.6.4 DYNAMIC COMPANIES 174
FIGURE 31 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 175
11.7 COMPETITIVE BENCHMARKING 176
TABLE 170 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF KEY PLAYERS 176
TABLE 171 PRODUCT FOOTPRINT OF COMPANIES 176
TABLE 172 GEOGRAPHICAL FOOTPRINT OF COMPANIES 177
11.8 COMPETITIVE SCENARIOS AND TRENDS 178
TABLE 173 KEY PRODUCT LAUNCHES 178
TABLE 174 KEY DEALS 178
TABLE 175 OTHER KEY DEVELOPMENTS 179
12 COMPANY PROFILES 180
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY PLAYERS 180
12.1.1 STRYKER 180
TABLE 176 STRYKER: COMPANY OVERVIEW 180
FIGURE 32 STRYKER: COMPANY SNAPSHOT (2022) 181
12.1.2 KARL STORZ SE & CO. KG 184
TABLE 177 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 184
12.1.3 CARL ZEISS MEDITEC AG 186
TABLE 178 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW 186
FIGURE 33 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022) 187
12.1.4 LEICA MICROSYSTEMS 189
TABLE 179 LEICA MICROSYSTEMS: COMPANY OVERVIEW 189
FIGURE 34 LEICA MICROSYSTEMS (DANAHER CORPORATION): COMPANY SNAPSHOT (2022) 190
12.1.5 OLYMPUS CORPORATION 193
TABLE 180 OLYMPUS CORPORATION: COMPANY OVERVIEW 193
FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 193
12.1.6 SHIMADZU CORPORATION 196
TABLE 181 SHIMADZU CORPORATION: COMPANY OVERVIEW 196
FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2021) 197
12.1.7 PERKINELMER, INC. 199
TABLE 182 PERKINELMER, INC.: COMPANY OVERVIEW 199
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 200
12.1.8 LI-COR, INC. 202
TABLE 183 LI-COR, INC.: COMPANY OVERVIEW 202
12.1.9 HAMAMATSU PHOTONICS K.K. 204
TABLE 184 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW 204
FIGURE 38 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022) 205
12.1.10 QUEST MEDICAL IMAGING B.V. 207
TABLE 185 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW 207
12.1.11 SIGMA-ALDRICH (MERCK) 208
TABLE 186 SIGMA-ALDRICH: COMPANY OVERVIEW 208
FIGURE 39 SIGMA-ALDRICH: COMPANY SNAPSHOT (2022) 208
12.1.12 MIZUHO MEDICAL CO., LTD. 210
TABLE 187 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW 210
12.1.13 TELEDYNE PRINCETON INSTRUMENTS 211
TABLE 188 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW 211
FIGURE 40 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2022) 212
12.1.14 THERMO FISHER SCIENTIFIC INC. 213
TABLE 189 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 213
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 214
12.1.15 FLUOPTICS 216
TABLE 190 FLUOPTICS: COMPANY OVERVIEW 216
12.1.16 MEDTRONIC 217
TABLE 191 MEDTRONIC: COMPANY OVERVIEW 217
12.1.17 CAYMAN CHEMICAL 218
TABLE 192 CAYMAN CHEMICAL: COMPANY OVERVIEW 218
12.1.18 MP BIOMEDICALS 219
TABLE 193 MP BIOMEDICALS: COMPANY OVERVIEW 219
12.1.19 CRYSTA-LYN CHEMICAL COMPANY 220
TABLE 194 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW 220
12.1.20 GOWERLABS LTD. 221
TABLE 195 GOWERLABS LTD.: COMPANY OVERVIEW 221
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 222
12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC 222
12.2.2 XENICS NV 222
12.2.3 BIOTIUM 223
12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD. 224
12.2.5 AAT BIOQUEST, INC. 224

13 APPENDIX 225
13.1 DISCUSSION GUIDE 225
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 CUSTOMIZATION OPTIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 研究用抗体・試薬の世界市場予測（～2028）：製品別、技術別、用途別、エンドユーザー別、地域別
  • 細胞ベースアッセイの世界市場予測（～2028）：製品＆サービス別、用途別、エンドユーザー別、地域別
  • 乳房画像診断/検査の世界市場予測（～2028）：技術別、製品別、エンドユーザー別
  • 電気生理学の世界市場予測（～2028）：製品別、疾患別、エンドユーザー別、地域別
  • 遠隔患者モニタリング（RPM）の世界市場予測（～2028）：製品別、エンドユーザー別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MD4138-23 )"近赤外線イメージングの世界市場予測（～2028）：製品別、処置別、用途別、エンドユーザー別、地域別" (英文：Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。